- Home
- TLSI vs WNEB Comparison
TLSI vs WNEB Comparison
Compare TLSI & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- WNEB
- Stock Information
- Founded
- TLSI 2010
- WNEB 1853
- Country
- TLSI United States
- WNEB United States
- Employees
- TLSI N/A
- WNEB N/A
- Industry
- TLSI Medical Specialities
- WNEB Savings Institutions
- Sector
- TLSI Health Care
- WNEB Finance
- Exchange
- TLSI Nasdaq
- WNEB Nasdaq
- Market Cap
- TLSI 166.8M
- WNEB 165.5M
- IPO Year
- TLSI N/A
- WNEB N/A
- Fundamental
- Price
- TLSI $4.73
- WNEB $8.90
- Analyst Decision
- TLSI Strong Buy
- WNEB Hold
- Analyst Count
- TLSI 2
- WNEB 4
- Target Price
- TLSI $14.00
- WNEB $8.50
- AVG Volume (30 Days)
- TLSI 69.8K
- WNEB 39.9K
- Earning Date
- TLSI 08-14-2024
- WNEB 10-22-2024
- Dividend Yield
- TLSI N/A
- WNEB 3.23%
- EPS Growth
- TLSI N/A
- WNEB N/A
- EPS
- TLSI N/A
- WNEB 0.63
- Revenue
- TLSI $24,736,000.00
- WNEB $74,435,000.00
- Revenue This Year
- TLSI $61.24
- WNEB N/A
- Revenue Next Year
- TLSI $47.32
- WNEB $5.16
- P/E Ratio
- TLSI N/A
- WNEB $13.68
- Revenue Growth
- TLSI 67.75
- WNEB N/A
- 52 Week Low
- TLSI $3.32
- WNEB $6.00
- 52 Week High
- TLSI $10.42
- WNEB $9.25
- Technical
- Relative Strength Index (RSI)
- TLSI 36.52
- WNEB 59.33
- Support Level
- TLSI $4.80
- WNEB $8.45
- Resistance Level
- TLSI $5.32
- WNEB $8.99
- Average True Range (ATR)
- TLSI 0.34
- WNEB 0.18
- MACD
- TLSI -0.02
- WNEB -0.05
- Stochastic Oscillator
- TLSI 3.06
- WNEB 37.04
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.